- ￥288 - 2800
- 联祖
- LZ-01X10094
- 国产
- 2025年12月19日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
45
- 英文名：
BMS-214662
- 保质期：
半年
- 供应商：
上海联祖
- 保存条件：
-20℃避光保存
- 规格：
1mL(10mM)|1mg|5mg|10mg|25mg|50mg|100mg
商品属性：
| 型号 | LZ-01X10094 |
| 英文名称 | BMS-214662 |
| 产品规格 | 1mL(10mM)|1mg|5mg|10mg|25mg|50mg|100mg |
| 发货周期 | 1～3天 |
商品描述：
BMS-214662是有效选择性的farnesyl transferase抑制剂，具有有效地抗肿瘤活性。
CAS号：195987-41-8
纯度：99.69%
分子量：489.61
储存条件：
低温运输、-20℃保存(但溶液B也可以常温运输和保存)，
有效期一年。
注意事项：
注：本品仅可用于科研实验，严禁用于临床医疗及其他用途！
下列是公司正在出售的产品：
Protective protein/Cathepsin A 组织蛋白酶A抗体 Rat 17-Hydroxyprogesterone, 17-OHP Elisa Kit
TFPI-2 组织因子途径抑制剂-2抗体 Rat Bone morphogenetic protein receptor 1A, BMPR-1A Elisa Kit
guinea pig Interleukin 6, IL-6 Elisa Kit
Porcine nitric oxide, NO Elisa Kit
Porcine Corticosterone, CORT Elisa Kit
Chicken Transforming Growth factor β2, TGF-β2 Elisa Kit
Chicken carbonic anhydrase, CA Elisa Kit
Human Cathepsin L1 ELISA Kit
Human fatty acid transport protein 5,FATP5 ELISA Kit
Human heterogeneous nuclear ribonucleoprotein R,hnRNP R ELISA Kit
Human Peroxiredoxin 4,PRDX4 ELISA Kit
farnesyl transferase抑制剂（BMS-214662）human STAT4 ELISA Kit
Human Hepatitis E virus antibody IgM ELISA Kit
Human Azurocidin/Heparin Binding Protein,AZU/HBP ELISA Kit
Human TrpV1 ELISA Kit
Human Trifunctional enzyme subunit beta, mitochondrial(HADHB)ELISA kit
6orf140 6号染色体开放阅读框140抗体 Human Clara cell protein ELISA Kit,Clara cell protein,CC16
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Biochemical and Biological Analyses of Farnesyl-Protein Transferase Inhibitors
Farnesyl-protein transferase (FPTase) catalyzes the postiranslational addition of the IScarbon isoprenoid, farnesyl, to approx 20 cellular proteins. Farnesylation is essential for the membrane localization and function of the modified
Immunohistochemical Assays of Farnesyltransferase Inhibition in Patient Samples
As a result of early reports indicating that farnesylation was required for maturation of Ras proteins, there has been extensive interest in farnesyl-transferase (FT) as a potential target of antineoplastic therapy (1 –3 ). At the present
Testing Antivirals Against Hepatitis Delta Virus: Farnesyl Transferase Inhibitors
Since the discovery of hepatitis delta virus (HDV) about 25 yr ago ( 1 – 3 ), no medical therapy has yet been developed to eradicate effectively this cause of acute and chronic liver disease. This small RNA virus is composed of three main
技术资料暂无技术资料 索取技术资料
